Detect anticoagulant antibodies: Identifies antibodies that may interfere with the body’s normal clotting mechanisms. Assess risk of blood clots: Presence of these antibodies is associated with increased risk of abnormal clotting, such as deep vein thrombosis or strokes. Diagnose immune disorders: Helps identify conditions like antiphospholipid syndrome, an immune-related clotting disorder. Patient monitoring: Used to follow up on patients with clotting disorders or related immune conditions.

Individuals with recurrent blood clots: Such as deep vein thrombosis or strokes, as the test is essential to determine the underlying cause. Patients with antiphospholipid syndrome: To confirm diagnosis and monitor their condition. Individuals with symptoms of immune disorders: Such as those with systemic lupus erythematosus, where these antibodies may be present. Pregnant women: With a history of blood clots, to assess risk during pregnancy. Individuals diagnosed with clotting disorders: To monitor treatment effectiveness and detect potential complications.

Recurrent blood clots: Such as deep vein thrombosis or strokes, without a clear cause. Leg symptoms: Pain or swelling that may indicate a blood clot. Personal or family history of clotting disorders: Requires further evaluation. Pregnancy-related issues: Such as recurrent miscarriages or complications during pregnancy. Symptoms of systemic lupus erythematosus (SLE): Such as severe fatigue, skin rashes, or joint problems.

What is the purpose of this test? It aims to detect antibodies that may increase the risk of blood clots. How is the test performed? A blood sample is drawn, frozen with an anticoagulant, and then analyzed to detect lupus anticoagulant. Are there any special preparations before the test? Usually, no special preparation is needed, but it is recommended to consult your doctor for specific instructions. How long does it take to get the results? Results are typically available within 2 days to a week, depending on the laboratory. What does the presence of anticoagulant antibodies indicate? It indicates an increased risk of blood clots or immune disorders such as antiphospholipid syndrome. What are the risks associated with blood draw? Risks are minimal and may include bruising or pain at the puncture site. What should I do if the results are positive? Consult your doctor to evaluate the condition and determine appropriate treatment options. Can other medications affect the test results? Yes, some medications may affect the results, so inform your doctor about all medications you are taking.

Positive result: Indicates the presence of lupus anticoagulant antibodies, which may suggest an increased risk of blood clots. Negative result: Indicates the absence of these antibodies, considered normal for this test.

Lupus Anticoagulant Test Price | Lahalak Platform

An advanced test to detect antibodies that increase clotting risk, helping diagnose autoimmune diseases and protect your vascular health.

Prices starts from: 132.56 SAR

Scientific name: Lupus Anticoagulant Test

The Lupus Anticoagulant (LA) test in citrated plasma is an important tool for evaluating risks associated with clotting disorders. This test is conducted to detect the presence of antibodies that affect the clotting process, which may increase the risk of blood clots or lead to conditions such as deep vein thrombosis or strokes. A sample of citrate...

Service type Laboratory test (Blood)

Duration 10-15 minutes

Fasting Fasting is not required

Prices Starting from 132.56 SAR

Included Services

Lupus Anticoagulant, Citrated Plasma Test
The optimal health guidance based on the result.
Personal support services from Lahalak

Medical Service Information

Purpose Test

Detect anticoagulant antibodies: Identifies antibodies that may interfere with the body’s normal clotting mechanisms.
Assess risk of blood clots: Presence of these antibodies is associated with increased risk of abnormal clotting, such as deep vein thrombosis or strokes.
Diagnose immune disorders: Helps identify conditions like antiphospholipid syndrome, an immune-related clotting disorder.
Patient monitoring: Used to follow up on patients with clotting disorders or related immune conditions.

Recommended groups

Individuals with recurrent blood clots: Such as deep vein thrombosis or strokes, as the test is essential to determine the underlying cause.
Patients with antiphospholipid syndrome: To confirm diagnosis and monitor their condition.
Individuals with symptoms of immune disorders: Such as those with systemic lupus erythematosus, where these antibodies may be present.
Pregnant women: With a history of blood clots, to assess risk during pregnancy.
Individuals diagnosed with clotting disorders: To monitor treatment effectiveness and detect potential complications.

Symptoms indicative

Recurrent blood clots: Such as deep vein thrombosis or strokes, without a clear cause.
Leg symptoms: Pain or swelling that may indicate a blood clot.
Personal or family history of clotting disorders: Requires further evaluation.
Pregnancy-related issues: Such as recurrent miscarriages or complications during pregnancy.
Symptoms of systemic lupus erythematosus (SLE): Such as severe fatigue, skin rashes, or joint problems.

FAQs

What is the purpose of this test? It aims to detect antibodies that may increase the risk of blood clots.
How is the test performed? A blood sample is drawn, frozen with an anticoagulant, and then analyzed to detect lupus anticoagulant.
Are there any special preparations before the test? Usually, no special preparation is needed, but it is recommended to consult your doctor for specific instructions.
How long does it take to get the results? Results are typically available within 2 days to a week, depending on the laboratory.
What does the presence of anticoagulant antibodies indicate? It indicates an increased risk of blood clots or immune disorders such as antiphospholipid syndrome.
What are the risks associated with blood draw? Risks are minimal and may include bruising or pain at the puncture site.

Normal Levels

Positive result: Indicates the presence of lupus anticoagulant antibodies, which may suggest an increased risk of blood clots.
Negative result: Indicates the absence of these antibodies, considered normal for this test.